EUVIMEDEUVIMED entdecken
Crossref

Clinicomycological Profile of Invasive Fungal Infections in Intensive Care Unit (ICU) Patients in tertiary care hospital

Tanushree Narain, Kumari Ritu, Pratulya Nandan, Vijay Kumar

International Journal of Pharmaceutical Quality Assurance · 09.07.2026 · 16 (10)

DOI: 10.25258/ijpqa.16.10.71 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Pharmaceutical Quality Assurance, online erschienen am 09.07.2026. Verfasst von Tanushree Narain und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Invasive fungal infections (IFIs) represent a significant cause of morbidity and mortality among patients admitted to intensive care units (ICUs). The increasing use of broad-spectrum antibiotics, invasive devices, prolonged hospitalization, and underlying immunosuppression has contributed to a rising incidence of IFIs. Early diagnosis based on laboratory evaluation is essential for timely management and improved clinical outcomes.

Aim

To assess the laboratory profile, fungal pathogen distribution, and clinical outcomes of invasive fungal infections in critically ill ICU patients. Methodology: A hospital-based observational study was conducted over a period of six months in the ICU of Patna Medical College and Hospital. Seventy patients aged 18 years and above with confirmed invasive fungal infections were included. Clinical specimens such as blood, sterile body fluids, and tissue samples were processed for fungal culture and species identification using standard mycological methods. Demographic details, clinical risk factors, and patient outcomes were recorded and analyzed using SPSS version 27.

Results

Most patients were male (60%), with the highest proportion belonging to the 41–60-year age group (41.4%). Prior antibiotic therapy (71.4%) and central venous catheterization (54.3%) were the most frequently observed risk factors. Candida species were the predominant pathogens, particularly Candida albicans (35.7%) and Candida tropicalis (17.1%), followed by Aspergillus species (22.9%). Recovery was observed in 71.4% of patients, while the mortality rate was 20%.

Conclusion

Candida species were the leading cause of IFIs in ICU patients. Early laboratory identification and clinicomycological profiling play a crucial role in improving patient outcomes.

Zitieren

APA

Narain, T., Ritu, K., Nandan, P., & Kumar, V. (2026). Clinicomycological Profile of Invasive Fungal Infections in Intensive Care Unit (ICU) Patients in tertiary care hospital. International Journal of Pharmaceutical Quality Assurance, 16(10). https://doi.org/10.25258/ijpqa.16.10.71

Vancouver

Narain T, Ritu K, Nandan P, Kumar V. Clinicomycological Profile of Invasive Fungal Infections in Intensive Care Unit (ICU) Patients in tertiary care hospital. International Journal of Pharmaceutical Quality Assurance. 2026;16(10). doi:10.25258/ijpqa.16.10.71

BibTeX
@article{Narain2026,
  author = {Narain, Tanushree and Ritu, Kumari and Nandan, Pratulya and Kumar, Vijay},
  title = {Clinicomycological Profile of Invasive Fungal Infections in Intensive Care Unit (ICU) Patients in tertiary care hospital},
  journal = {International Journal of Pharmaceutical Quality Assurance},
  year = {2026},
  volume = {16},
  number = {10},
  doi = {10.25258/ijpqa.16.10.71}
}
Kostenlos starten →